DNA Genotek Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 179

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50.5M

DNA Genotek General Information

Description

Provider of oral fluid sample collection, stabilization and preparation products created for molecular diagnostic applications. The company offers DNA and RNA collection kits, stabilization reagents, expression profiling, preparation reagents, nucleic acid extraction, SNP genotyping and bioinformatic analysis, enabling physicians to collect samples in least invasive ways and reduce pain for patients.

Contact Information

Website
www.dnagenotek.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Laboratory Services (Healthcare)
Parent Company
Orasure Technologies
Primary Office
  • 3000 - 500 Palladium Drive
  • Ottawa, Ontario K2V 1C2
  • Canada
+1 (866) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNA Genotek Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 30-Sep-2011 $50.5M 000.00 Completed Profitable
1. Early Stage VC 01-Jan-2001 Completed Startup
To view DNA Genotek’s complete valuation and funding history, request access »

DNA Genotek Patents

  • 182

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 117

    Granted

  • 27

    Pending

  • 000

    Expiring in next 12 mo

DNA Genotek Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D967455-S1 Tube and cap spacer Active 21-Jan-2021 0
CA-204815-S Tube and cap spacer Active 21-Jan-2021
EP-4136427-A1 Stabilizing composition and method for preserving a bodily fluid Pending 30-Mar-2020 00000000
CA-3178146-A1 Stabilizing composition and method for preserving a bodily fluid Pending 30-Mar-2020 00000000
JP-2023520533-A Stabilized compositions and methods for preserving bodily fluids Pending 30-Mar-2020 C12N1/04
To view DNA Genotek’s complete patent history, request access »

DNA Genotek Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNA Genotek Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Purple Angel Angel Group Minority 000 0000 000000 0
To view DNA Genotek’s complete investors history, request access »

Ready to get started?

Request a free trial